Skip to main navigation Skip to search Skip to main content

Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report

    Research output: Contribution to Journal › Article › Academic › peer-review

    Abstract

    Central giant cell granuloma is a benign lesion of the jaws which is sometimes aggressive locally. The most common treatment is curettage which has a high recurrence rate. particularly, in more aggressive lesions. Other treatments Such as interferon (IFN) and calcitonin have been described. We report a patient with Stickler syndrome and in aggressive central giant cell granuloma in the mandible. Initial treatment with calcitonin was not successful. A combination of IFN and imatinib, given for 9 months, initiated regression of the lesion that Continued after treatment had ceased.
    Original languageEnglish
    Pages (from-to)59-61
    JournalBritish Journal of Oral & Maxillofacial Surgery
    Volume47
    Issue number1
    DOIs
    Publication statusPublished - 2009

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report'. Together they form a unique fingerprint.

    Cite this